<DOC>
	<DOC>NCT00580684</DOC>
	<brief_summary>To compare the ability of Prevnar® to Pneumo® 23 in reducing and preventing nasopharyngeal carriage of vaccine-type pneumococci one year after respective immunization. To evaluate the rate of penicillin-resistant pneumococci in nasopharyngeal carriage.</brief_summary>
	<brief_title>Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children</brief_title>
	<detailed_description>This study will require 6 months to be completed (3 months for nasopharyngeal samples collection; 3 months dor analysis). Each child will participate for a 1 day period.</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy children between 2 to 9 years old. No history of antibiotic use prior 1 month of enrollment No history of invasive pneumococcal disease</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>pneumococcus conjugated vaccine 7 valent</keyword>
</DOC>